Clinical and laboratory manifestations of anti-factor V antibodies
Author:
- 1 April 1999
- journal article
- review article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 133 (4) , 326-334
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Epidemiology of Inhibitors in Haemophilia AVox Sanguinis, 1996
- Thrombin-Catalyzed Activation of Recombinant Human Factor VBiochemistry, 1995
- Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine ThrombinJournal of Pediatric Hematology/Oncology, 1994
- Inhibition of prothrombin activation by antiphospholipid antibodies and β2‐glycoprotein 1British Journal of Haematology, 1994
- Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosisAmerican Journal of Hematology, 1994
- Severe bleeding caused by an inhibitor to coagulation factor VBlood Coagulation & Fibrinolysis, 1994
- Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old childActa Paediatrica, 1994
- Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patientsJournal of Neurosurgery, 1993
- COFACTOR PROTEINS IN THE ASSEMBLY AND EXPRESSION OF BLOOD CLOTTING ENZYME COMPLEXESAnnual Review of Biochemistry, 1988
- The Regulation of Hemostasis: The Protein C SystemNew England Journal of Medicine, 1986